We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XProduct
December 9, 2010
Synthesised from both hydrophilic and hydrophobic monomers, the amphiphilic Adapt™ system provides exquisite control over drug release and can be easily tailored, through simple adjustment in the monomer ratios, to afford customised release profiles and bespoke physical properties.
Long-term stability, enhanced tissue and blood compatibility and highly tuneable drug delivery makes the Adapt™ Biostable Drug Delivery Platform ideally suited for site-targeted drug delivery applications, such as drug eluting stents.
For more information on Adapt™ please download our overview document.